covina, April 25, 2023 (GLOBE NEWSWIRE) -- Automated Breast Ultrasound Systems is a secondary screening designed for women with dense breasts, this machines able to identify dense breast tissues in female. Automated Breast Ultrasound Systems is advanced technique featured with high frequency transducers for reproduction of images with superior quality.
Growing breast cancer incidence has contributed in target market growth. Growing demand for advanced breast imaging technologies for effective treatment has further facilitated the target market growth. Government initiative and various foundation programs for awareness of cancer disease is expected to fruitful the demand for Automated Breast Ultrasound Systems market growth in future.
The report “Automated Breast Ultrasound Systems (ABUS) Market, By Type (Automated Breast Ultrasound Systems(ABUS) and Automated Breast Volume Scanner (ABVS)), By Application (Hospitals and Diagnostic Imaging Centers), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032”
Key Highlights:
- In February2023, Seno Medical Instruments Inc., launched new “imagio Breast Imaging System” which received supplemental premarket approval from U.S. FDA (Food and Drug Administration), Center for Devices and Radiological Health (CDRH). New launched product is featured with advanced ultrasound technology integrated with new ultrasound probe and significantly help in reducing costs with its non-invasive OA/US innovation.
Analyst View:
Automated Breast Ultrasound Systems (ABUS) Market looks promising to grow in future driven by growing demand for personalized medicine as the patients and healthcare providers are increasing seeking personalized approaches to breast cancer screening and diagnosis. As the technology continues to evolve, it is likely that ABUS will become an increasingly important tool in the fight against breast cancer. Advances in technology are expected to continue to make Automated Breast Ultrasound Systems more efficient, user-friendly, and affordable, making them more accessible to a wider range of healthcare providers and patients.
Before purchasing this report, request a sample or make an inquiry by clicking the following link:
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/3382
Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Automated Breast Ultrasound Systems (ABUS) Market, By Type (Automated Breast Ultrasound Systems (ABUS) and Automated Breast Volume Scanner (ABVS)), By Application (Hospitals and Diagnostic Imaging Centers), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032”
Key Market Insights from the report:
Automated Breast Ultrasound Systems (ABUS) Market accounted for US$ 1.74 billion in 2022 and is estimated to be US$ 8.52 billion by 2032 and is anticipated to register a CAGR of 17.4%. Automated Breast Ultrasound Systems (ABUS) Market is segmented based on Type, Application and Region.
- Based on Type, Automated Breast Ultrasound Systems (ABUS) Market is segmented into Automated Breast Ultrasound Systems(ABUS) and Automated Breast Volume Scanner (ABVS).
- Based on Application, Automated Breast Ultrasound Systems (ABUS) Market is segmented into Hospitals and Diagnostic Imaging Centers.
- By Region, the Automated Breast Ultrasound Systems (ABUS) Market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Request Customization: https://www.prophecymarketinsights.com/market_insight/Insight/request-customization/3382
Competitive Landscape & their strategies of Automated Breast Ultrasound Systems (ABUS) Market:
The prominent players operating in the Automated Breast Ultrasound Systems (ABUS) Market includes
- GE Healthcare
- Hitachi Ltd.
- Koninklijke Philips N.V.
- Siemens AG
- SonoCine Inc.
- QView Medical,Inc.
- Seno Medical Instruments Inc.
- Volpara Solutions
- Delphinus Medical Technologies Inc.
- CapeRay and others.
Related Reports:
- Breast Cancer Diagnostics Market, By Test (Mammogram, Blood Test, Breast Magnetic Resonance Imaging (MRI), Biopsy, Breast Ultrasound, and Others), By Application (Research, Screening, Prognostic, and Others), By End-Users (Clinics, Hospitals, Medical Laboratories, Diagnostic Centers, and Others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032
- Global HER2-Positive Breast Cancer Market, By Treatment Type (Targeted Therapy, Chemotherapy, Endocrine Therapy, Immunotherapy and Others), By Route of Administration (Parenteral, Oral and Others), By Application (Hospital, Biotechnology & Pharmaceuticals company, Specialty Clinics, Research & Academic Institution and Others), By Distribution Channel ( Hospital pharmacy, Retail pharmacy and Online pharmacy) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030
About us:
Prophecy Market Insights is specialized market research, marketing/business strategy, analytics, and solutions that offer strategic support to clients for making well-informed business decisions and identifying and achieving high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome transform and advance their businesses with growth.
